Margaret Wierman is an Endocrinology/Metabolic physician affiliated with University of Colorado Anschutz Medical Campus. OpenAlex indexes 287 publications with 9,627 citations (h-index 53); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Bioenergetic Effects of Aging and Menopause (BEAM)
Sponsor: University of Colorado, Denver
- Neuroendocrine Dysfunction in Traumatic Brain Injury: Correlation With Cognitive Dysfunction and Repair
Sponsor: Denver Research Institute
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
2 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
38.9%l-Thyroxine33.8%Levothyroxine Sodium77%Synthroid23%Part D<11 patientsMineralocorticoids5.1%Fludrocortisone Acetate100%Part D<11 patientsMetabolism & gastrointestinal
34.5%Corticosteroid21.5%Prednisone100%Part D≥19 patientsBiguanide (metformin)8.9%Metformin Hcl100%Part D<11 patients+ 1 more class in this area
Nervous system
11.6%Ergot Derivative11.6%Cabergoline100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
9 NIH research awards on record, funded 1988–2024 per NIH RePORTER. The latest:
- Targeting Kinases in Novel Preclinical Models of Adrenocortical Carcinoma
Va Eastern Colorado Health Care System
FY2024I01BX004665 - Targeting Kinases in Novel Preclinical Models of Adrenocortical Carcinoma
Va Eastern Colorado Health Care System
FY2023I01BX004665 - Targeting Kinases in Novel Preclinical Models of Adrenocortical Carcinoma
Va Eastern Colorado Health Care System
FY2022I01BX004665
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Schulick, MD, MBA
University of Colorado Anschutz Medical Campus
John Rumsfeld, MD, PhD
University of Colorado Anschutz Medical Campus
Robert Eckel, MD
University of Colorado Anschutz Medical Campus
Marc Bonaca, MD
University of Colorado Anschutz Medical Campus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”